Industries > Pharma > Allergy Treatment Market Report to 2031
Allergy Treatment Market Report to 2031
Forecasts By Type (Eye Allergy, Skin Allergy, Food Allergy, Asthma, Rhinitis, and Others), By Treatment (Anti-Allergy Drugs and Immunotherapy), By Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and Online Retailers) PLUS COVID-19 Recovery Scenarios
Allergy Treatment Market– our new study reveals trends, R&D progress, and predicted revenues
Where is the Allergy Treatment market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 500+ page report provides 600+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Allergy Treatment Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Allergy Treatment Market: By Type
• Eye Allergy
• Skin Allergy
• Food Allergy
• Asthma
• Rhinitis
• Others
Allergy Treatment Market: By Treatment
• Anti-Allergy Drugs
• Immunotherapy
Allergy Treatment Market: By Distribution Channels
• Hospital Pharmacies
• Retail Pharmacies
• Online Retailers
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Allergy Treatment Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Allergy Treatment Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Allergy Treatment Market report helps you
In summary, our 500+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Allergy Treatment Market, with forecasts for Type, Treatment, and Distribution Channel, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Allergy Treatment market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Allergy Treatment Market. Some of the company’s profiled in this report include Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc. and Vicks.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Allergy Treatment Market Report to 2031: Forecasts By Type (Eye Allergy, Skin Allergy, Food Allergy, Asthma, Rhinitis, and Others), By Treatment (Anti-Allergy Drugs and Immunotherapy), By Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and Online Retailers) PLUS COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Allergy Immunotherapy Market
2.1. Allergy Immunotherapy Market Definition
2.2. Type Submarkets Definitions
2.3. Treatment Submarkets Definitions
2.4. Distribution Channel Submarkets Definitions
3. Allergy Immunotherapy Market Overview
3.1. Global Allergy Immunotherapy Market Size and Forecast by Region
3.2. Global Allergy Immunotherapy Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Rise in the prevalence of allergic disorders
3.3.1.2. Presence for strong product pipeline
3.3.1.3. The rising importance for self-medication
3.3.1.4. Increase in incidence of food allergies across the globe
3.3.1.5. Increased investment by the manufacturers on the development of novel allergic treatments
3.3.1.6. Increase In Risk Factors Causing Allergies
3.3.1.7. Rising Screening For Allergy And Reimbursement Scenario
3.3.2. Market Restraints/Challenges
3.3.2.1. Rise in preference towards the use of biosimilar
3.3.2.2. Low awareness of allergy immunotherapy (AIT) among patients
3.3.3. Opportunities
3.3.3.1. Innovative developments in the field of immunotherapy
3.3.4. Global Allergy Immunotherapy Market: Trends
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.2. Weaknesses
3.3.5.3. Opportunities
3.3.5.4. Threats
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. The threat of New Entry
4. Global Allergy Immunotherapy Market Analysis and Forecast, 2021-2031 by Type (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Eye Allergy
4.1.2. Skin Allergy
4.1.3. Food Allergy
4.1.4. Asthma
4.1.5. Rhinitis
4.1.6. Others
5. Global Allergy Immunotherapy Market Analysis and Forecast 2021-2031, by Treatment (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Anti-Allergy Drugs
5.1.2. Immunotherapy
6. Global Allergy Immunotherapy Market Analysis and Forecast, 2021-2031 by Distribution Channel (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Hospital Pharmacy
6.1.2. Retail Pharmacy
6.1.3. Online Pharmacy
7. North America Allergy Immunotherapy Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. North America Allergy Immunotherapy Market Size and Forecast by Type
7.3. North America Allergy Immunotherapy Market Size and Forecast by Treatment
7.4. North America Allergy Immunotherapy Market Size and Forecast by Distribution Channel
7.5. U.S. Allergy Immunotherapy Market
7.6. Canada Allergy Immunotherapy Market
8. Europe Allergy Immunotherapy Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Europe Allergy Immunotherapy Market Size and Forecast by Type
8.3. Europe Allergy Immunotherapy Market Size and Forecast by Treatment
8.4. Europe Allergy Immunotherapy Market Size and Forecast by Distribution Channel
8.5. UK Allergy Immunotherapy Market
8.6. Germany Allergy Immunotherapy Market
8.7. France Allergy Immunotherapy Market
8.8. Rest of Europe Allergy Immunotherapy Market
9. Asia Pacific Allergy Immunotherapy Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Asia Pacific Allergy Immunotherapy Market Size and Forecast by Type
9.3. Asia Pacific Allergy Immunotherapy Market Size and Forecast by Treatment
9.4. Asia Pacific Allergy Immunotherapy Market Size and Forecast by Distribution Channel
9.5. China Allergy Immunotherapy Market
9.6. India Allergy Immunotherapy Market
9.7. Japan Allergy Immunotherapy Market
9.8. Rest of Asia Pacific Allergy Immunotherapy Market
10. Latin America Allergy Immunotherapy Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Latin America Allergy Immunotherapy Market Size and Forecast by Type
10.3. Latin America Allergy Immunotherapy Market Size and Forecast by Treatment
10.4. Latin America Allergy Immunotherapy Market Size and Forecast by Distribution Channel
10.4.1. Brazil Allergy Immunotherapy Market
10.4.2. Mexico Allergy Immunotherapy Market
10.4.3. Rest of Latin America Allergy Immunotherapy Market
11. MEA Allergy Immunotherapy Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. MEA Allergy Immunotherapy Market Size and Forecast by Type
11.3. MEA Allergy Immunotherapy Market Size and Forecast by Treatment
11.4. MEA Allergy Immunotherapy Market Size and Forecast by Distribution Channel
11.5. GCC Allergy Immunotherapy Market
11.6. South Africa Allergy Immunotherapy Market
11.7. Rest of MEA Allergy Immunotherapy Market
12. Companies in the Allergy Immunotherapy Market
12.1. Schering-Plough Corporation
12.1.1. Company Snapshot
12.1.2. Company Overview
12.1.3. Financial Performance (2015-2019)
12.1.3.1. Net Revenue
12.1.3.2. Gross Profit
12.1.3.3. Geographical Revenue, 2019
12.1.4. Product Offerings
12.1.5. Recent Initiatives (2017-2019)
12.2. Allergopharma
12.2.1. Company Snapshot
12.2.2. Company Overview
12.2.3. Financial Performance (2015-2019)
12.2.3.1. Net Revenue
12.2.3.2. Gross Profit
12.2.3.3. Geographical Revenue, 2019
12.2.4. Product Offerings
12.2.5. Recent Initiatives (2017-2019)
12.3. Allergon AB
12.3.1. Company Snapshot
12.3.2. Company Overview
12.3.3. Financial Performance (2015-2019)
12.3.3.1. Net Revenue
12.3.3.2. Gross Profit
12.3.3.3. Geographical Revenue, 2019
12.3.4. Product Offerings
12.3.5. Recent Initiatives (2017-2019)
12.4. Alerpharma S.A.
12.4.1. Company Snapshot
12.4.2. Company Overview
12.4.3. Financial Performance (2015-2019)
12.4.3.1. Net Revenue
12.4.3.2. Gross Profit
12.4.3.3. Geographical Revenue, 2019
12.4.4. Product Offerings
12.4.5. Recent Initiatives (2017-2019)
12.5. Allergan, Inc.
12.5.1. Company Snapshot
12.5.2. Company Overview
12.5.3. Financial Performance (2015-2019)
12.5.3.1. Net Revenue
12.5.3.2. Gross Profit
12.5.3.3. Geographical Revenue, 2019
12.5.4. Product Offerings
12.5.5. Recent Initiatives (2017-2019)
12.6. Genentech Inc.
12.6.1. Company Snapshot
12.6.2. Company Overview
12.6.3. Financial Performance (2015-2019)
12.6.3.1. Net Revenue
12.6.3.2. Gross Profit
12.6.3.3. Geographical Revenue, 2019
12.6.4. Product Offerings
12.6.5. Recent Initiatives (2017-2019)
12.7. Schering-Plough Corporation
12.7.1. Company Snapshot
12.7.2. Company Overview
12.7.3. Financial Performance (2015-2019)
12.7.3.1. Net Revenue
12.7.3.2. Gross Profit
12.7.3.3. Geographical Revenue, 2019
12.7.4. Product Offerings
12.7.5. Recent Initiatives (2017-2019)
12.8. McNeil Consumer Healthcare
12.8.1. Company Snapshot
12.8.2. Company Overview
12.8.3. Financial Performance (2015-2019)
12.8.3.1. Net Revenue
12.8.3.2. Gross Profit
12.8.3.3. Geographical Revenue, 2019
12.8.4. Product Offerings
12.8.5. Recent Initiatives (2017-2019)
12.9. Collegium Pharmaceutical, Inc.
12.9.1. Company Snapshot
12.9.2. Company Overview
12.9.3. Financial Performance (2015-2019)
12.9.3.1. Net Revenue
12.9.3.2. Gross Profit
12.9.3.3. Geographical Revenue, 2019
12.9.4. Product Offerings
12.9.5. Recent Initiatives (2017-2019)
12.10. Meda Pharmaceuticals, Inc.
12.10.1. Company Snapshot
12.10.2. Company Overview
12.10.3. Financial Performance (2015-2019)
12.10.3.1. Net Revenue
12.10.3.2. Gross Profit
12.10.3.3. Geographical Revenue, 2019
12.10.4. Product Offerings
12.10.5. Recent Initiatives (2017-2019)
12.11. Other Notable Players
13. Conclusion
14. Glossary
Associated Visiongain Reports
Visiongain Report Sales Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1 Allergy Immunotherapy Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2 Allergy Immunotherapy Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3 Allergy Immunotherapy Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4 Allergy Immunotherapy Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5 Allergy Immunotherapy Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6 Allergy Immunotherapy Market Drivers & Restraints 2020
Table 7 Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 8 Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 9 Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 10 Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 11 Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 12 Eye Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13 Eye Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14 Eye Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15 Eye Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16 Eye Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17 Skin Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 18 Skin Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 19 Skin Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 20 Skin Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 21 Food Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 22 Food Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 23 Food Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 24 Food Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 25 Food Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 26 Asthma Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 27 Asthma Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 28 Asthma Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 29 Asthma Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 30 Asthma Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 31 Rhinitis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 32 Rhinitis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 33 Rhinitis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 34 Rhinitis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 35 Rhinitis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 36 Other Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 37 Other Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 38 Other Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 39 Other Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 40 Other Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 41 Allergy Immunotherapy Submarket Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 42 Allergy Immunotherapy Submarket Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 43 Allergy Immunotherapy Submarket Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 44 Allergy Immunotherapy Submarket Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 45 Allergy Immunotherapy Submarket Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 46 Anti-Allergy Drugs Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) before COVID)
Table 47 Anti-Allergy Drugs Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 48 Anti-Allergy Drugs Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 49 Anti-Allergy Drugs Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 50 Anti-Allergy Drugs Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 51 Immunotherapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 52 Immunotherapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 53 Immunotherapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 54 Immunotherapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 55 Immunotherapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 56 Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 57 Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 58 Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 59 Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 60 Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 61 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 62 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 63 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 64 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 65 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 66 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 67 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 68 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 69 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 70 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 71 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 72 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 73 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 74 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 75 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 76 Regional Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 77 Regional Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 78 Regional Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 79 Regional Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 80 Regional Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 81 North America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 82 North America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 83 North America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 84 North America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 85 North America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 86 North America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 87 North America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 88 North America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 89 North America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 90 North America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 91 North America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 92 North America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 93 North America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 94 North America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 95 North America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 96 North America Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 97 North America Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 98 North America Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 99 North America Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 100 North America Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 101 US Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 102 US Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 103 US Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 104 US Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 105 US Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 106 Canada Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 107 Canada Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 108 Canada Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 109 Canada Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 110 Canada Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 111 Europe Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 112 Europe Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 113 Europe Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 114 Europe Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 115 Europe Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 116 Europe Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 117 Europe Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 118 Europe Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 119 Europe Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 120 Europe Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 121 Europe Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 122 Europe Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 123 Europe Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 124 Europe Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 125 Europe Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 126 Europe Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 127 Europe Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 128 Europe Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 129 Europe Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 130 Europe Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 131 UK Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 132 UK Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 133 UK Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 134 UK Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 135 UK Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 136 Germany Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 137 Germany Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 138 Germany Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 139 Germany Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 140 Germany Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 141 France Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 142 France Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 143 France Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 144 France Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 145 France Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 146 Rest of Europe Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 147 Rest of Europe Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 148 Rest of Europe Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 149 Rest of Europe Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 150 Rest of Europe Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 151 Asia Pacific Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 152 Asia Pacific Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 153 Asia Pacific Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 154 Asia Pacific Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 155 Asia Pacific Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 156 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 157 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 158 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 159 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 160 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 161 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 162 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 163 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 164 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 165 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 166 Asia Pacific Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 167 Asia Pacific Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 168 Asia Pacific Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 169 Asia Pacific Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 170 Asia Pacific Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 171 China Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 172 China Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 173 China Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 174 China Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 175 China Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 176 India Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 177 India Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 178 India Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 179 India Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 180 India Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 181 Japan Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 182 Japan Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 183 Japan Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 184 Japan Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 185 Japan Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 186 RoAPAC Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 187 RoAPAC Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 188 RoAPAC Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 189 RoAPAC Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 190 RoAPAC Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 191 Middle East Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 192 Middle East Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 193 Middle East Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 194 Middle East Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 195 Middle East Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 196 Middle East Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 197 Middle East Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 198 Middle East Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 199 Middle East Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 200 Middle East Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 201 Middle East Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 202 Middle East Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 203 Middle East Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 204 Middle East Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 205 Middle East Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 206 Latin America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 207 Latin America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 208 Latin America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 209 Latin America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 210 Latin America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 211 Latin America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 212 Latin America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 213 Latin America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 214 Latin America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 215 Latin America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 216 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 217 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 218 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 219 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 220 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 221 Africa Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 222 Africa Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 223 Africa Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 224 Africa Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 225 Africa Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 226 Africa Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 227 Africa Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 228 Africa Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 229 Africa Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 230 Africa Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 231 Africa Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 232 Africa Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233 Africa Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234 Africa Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235 Africa Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236 Leading 10 Allergy Immunotherapy Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 237 Allergy therapeutics Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 238 Allergy therapeutics Allergy Immunotherapy Selected Recent Contracts 2019 (Date, Contract Type, Details)
Table 239 Allergy therapeutics Allergy Immunotherapy Product Offering (Segment, Product Offerings)
Table 240 Allergopharma Profile 2019 (CEO, HQ, Founded, Website)
Table 241 Allergopharma Allergy Immunotherapy Selected Recent Contracts 2019 (Date, Contract Type, Details)
Table 242 Allergopharma Allergy Immunotherapy Product Offering (Segment, Product Offerings)
Table 243 Allergon AB Profile 2019 (CEO, HQ, Founded, Website)
Table 244 Allergon AB Allergy Immunotherapy Selected Recent Contracts 2017-2019 (Date, Contract Type, Details)
Table 245 Allergon AB Allergy Immunotherapy Product Offering (Segment, Product Offerings)
Table 246 Alerpharma S.A. Profile 2019 (CEO, HQ, Founded, Website)
Table 247 Alerpharma S.A. Allergy Immunotherapy Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 248 Alerpharma S.A. Allergy Immunotherapy Product Offering (Segment, Product Offerings)
Table 249 Allergan, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 250 Allergan, Inc. Allergy Immunotherapy Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 251 Allergan, Inc. Allergy Immunotherapy Product Offering (Segment, Product Offerings)
Table 252 Genentech Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 253 Genentech Inc. Allergy Immunotherapy Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 254 Genentech Inc. Allergy Immunotherapy Product Offering (Segment, Product Offerings)
Table 255 Schering-Plough Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 256 Schering-Plough Corporation Allergy Immunotherapy Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 257 Schering-Plough Corporation Allergy Immunotherapy Product Offering (Segment, Product Offerings)
Table 258 McNeil Consumer Healthcare Profile 2019 (CEO, HQ, Founded, Website)
Table 259 McNeil Consumer Healthcare Allergy Immunotherapy Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 260 McNeil Consumer Healthcare Allergy Immunotherapy Product Offering (Segment, Product Offerings)
Table 261 Collegium Pharmaceutical, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 262 Collegium Pharmaceutical, Inc. Allergy Immunotherapy Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 263 Collegium Pharmaceutical, Inc. Allergy Immunotherapy Product Offering (Segment, Product Offerings)
Table 264 Meda Pharmaceuticals, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 265 Meda Pharmaceuticals, Inc. Allergy Immunotherapy Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 266 Meda Pharmaceuticals, Inc. Allergy Immunotherapy Product Offering (Segment, Product Offerings)
Table 267 Other Companies Involved in the Allergy Immunotherapy Market 2020 (Company, Location)
LIST OF FIGURES
Figure 1 Allergy Immunotherapy Market by Treatment Overview
Figure 2 Allergy Immunotherapy Market by Treatment Overview
Figure 3 Allergy Immunotherapy Market by Treatment Overview
Figure 4 Allergy Immunotherapy Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 5 Allergy Immunotherapy Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 6 Allergy Immunotherapy Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 7 Allergy Immunotherapy Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 8 Allergy Immunotherapy Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 9 Allergy Immunotherapy Market Drivers & Restraints 2020
Figure 10 Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 11 Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 12 Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 13 Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 14 Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 15 Eye Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 16 Eye Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 17 Eye Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 18 Eye Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 19 Eye Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 20 Skin Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 21 Skin Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 22 Skin Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 23 Skin Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 24 Food Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 25 Food Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 26 Food Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 27 Food Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 28 Food Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 29 Asthma Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 30 Asthma Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 31 Asthma Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 32 Asthma Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 33 Asthma Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 34 Rhinitis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 35 Rhinitis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 36 Rhinitis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 37 Rhinitis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 38 Rhinitis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 39 Other Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 40 Other Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 41 Other Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 42 Other Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 43 Other Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 44 Allergy Immunotherapy Submarket Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 45 Allergy Immunotherapy Submarket Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 46 Allergy Immunotherapy Submarket Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 47 Allergy Immunotherapy Submarket Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 48 Allergy Immunotherapy Submarket Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 49 Anti-Allergy Drugs Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) before COVID)
Figure 50 Anti-Allergy Drugs Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 51 Anti-Allergy Drugs Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 52 Anti-Allergy Drugs Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 53 Anti-Allergy Drugs Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 54 Immunotherapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 55 Immunotherapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 56 Immunotherapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 57 Immunotherapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 58 Immunotherapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 59 Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 60 Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 61 Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 62 Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 63 Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 64 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 65 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 66 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 67 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 68 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 69 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 70 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 71 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 72 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 73 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 74 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 75 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 76 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 77 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 78 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 79 Regional Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 80 Regional Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 81 Regional Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 82 Regional Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 83 Regional Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 84 North America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 85 North America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 86 North America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 87 North America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 88 North America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 89 North America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 90 North America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 91 North America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 92 North America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 93 North America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 94 North America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 95 North America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 96 North America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 97 North America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 98 North America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 99 North America Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 100 North America Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 101 North America Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 102 North America Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 103 North America Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 104 US Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 105 US Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 106 US Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 107 US Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 108 US Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 109 Canada Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 110 Canada Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 111 Canada Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 112 Canada Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 113 Canada Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 114 Europe Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 115 Europe Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 116 Europe Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 117 Europe Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 118 Europe Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 119 Europe Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 120 Europe Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 121 Europe Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 122 Europe Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 123 Europe Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 124 Europe Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 125 Europe Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 126 Europe Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 127 Europe Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 128 Europe Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 129 Europe Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 130 Europe Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 131 Europe Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 132 Europe Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 133 Europe Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 134 UK Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 135 UK Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 136 UK Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 137 UK Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 138 UK Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 139 Germany Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 140 Germany Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 141 Germany Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 142 Germany Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 143 Germany Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 144 France Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 145 France Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 146 France Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 147 France Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 148 France Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 149 Rest of Europe Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 150 Rest of Europe Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 151 Rest of Europe Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 152 Rest of Europe Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 153 Rest of Europe Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 154 Asia Pacific Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 155 Asia Pacific Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 156 Asia Pacific Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 157 Asia Pacific Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 158 Asia Pacific Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 159 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 160 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 161 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 162 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 163 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 164 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 165 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 166 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 167 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 168 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 169 Asia Pacific Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 170 Asia Pacific Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 171 Asia Pacific Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 172 Asia Pacific Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 173 Asia Pacific Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 174 China Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 175 China Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 176 China Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 177 China Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 178 China Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 179 India Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 180 India Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 181 India Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 182 India Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 183 India Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 184 Japan Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 185 Japan Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 186 Japan Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 187 Japan Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 188 Japan Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 189 RoAPAC Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 190 RoAPAC Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 191 RoAPAC Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 192 RoAPAC Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 193 RoAPAC Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 194 Middle East Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 195 Middle East Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 196 Middle East Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 197 Middle East Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 198 Middle East Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 199 Middle East Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 200 Middle East Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 201 Middle East Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 202 Middle East Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 203 Middle East Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 204 Middle East Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 205 Middle East Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 206 Middle East Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 207 Middle East Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 208 Middle East Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 209 Latin America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 210 Latin America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 211 Latin America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 212 Latin America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 213 Latin America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 214 Latin America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 215 Latin America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 216 Latin America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 217 Latin America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 218 Latin America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 219 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 220 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 221 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 222 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 223 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 224 Africa Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 225 Africa Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 226 Africa Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 227 Africa Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 228 Africa Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 229 Africa Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 230 Africa Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 231 Africa Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 232 Africa Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 233 Africa Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 234 Africa Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 235 Africa Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 236 Africa Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 237 Africa Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 238 Africa Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Allergy Immunotherapy Market
2.1. Allergy Immunotherapy Market Definition
2.2. Type Submarkets Definitions
2.3. Treatment Submarkets Definitions
2.4. Distribution Channel Submarkets Definitions
3. Allergy Immunotherapy Market Overview
3.1. Global Allergy Immunotherapy Market Size and Forecast by Region
3.2. Global Allergy Immunotherapy Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Rise in the prevalence of allergic disorders
3.3.1.2. Presence for strong product pipeline
3.3.1.3. The rising importance for self-medication
3.3.1.4. Increase in incidence of food allergies across the globe
3.3.1.5. Increased investment by the manufacturers on the development of novel allergic treatments
3.3.1.6. Increase In Risk Factors Causing Allergies
3.3.1.7. Rising Screening For Allergy And Reimbursement Scenario
3.3.2. Market Restraints/Challenges
3.3.2.1. Rise in preference towards the use of biosimilar
3.3.2.2. Low awareness of allergy immunotherapy (AIT) among patients
3.3.3. Opportunities
3.3.3.1. Innovative developments in the field of immunotherapy
3.3.4. Global Allergy Immunotherapy Market: Trends
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.2. Weaknesses
3.3.5.3. Opportunities
3.3.5.4. Threats
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. The threat of New Entry
4. Global Allergy Immunotherapy Market Analysis and Forecast, 2021-2031 by Type (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Eye Allergy
4.1.2. Skin Allergy
4.1.3. Food Allergy
4.1.4. Asthma
4.1.5. Rhinitis
4.1.6. Others
5. Global Allergy Immunotherapy Market Analysis and Forecast 2021-2031, by Treatment (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Anti-Allergy Drugs
5.1.2. Immunotherapy
6. Global Allergy Immunotherapy Market Analysis and Forecast, 2021-2031 by Distribution Channel (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Hospital Pharmacy
6.1.2. Retail Pharmacy
6.1.3. Online Pharmacy
7. North America Allergy Immunotherapy Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. North America Allergy Immunotherapy Market Size and Forecast by Type
7.3. North America Allergy Immunotherapy Market Size and Forecast by Treatment
7.4. North America Allergy Immunotherapy Market Size and Forecast by Distribution Channel
7.5. U.S. Allergy Immunotherapy Market
7.6. Canada Allergy Immunotherapy Market
8. Europe Allergy Immunotherapy Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Europe Allergy Immunotherapy Market Size and Forecast by Type
8.3. Europe Allergy Immunotherapy Market Size and Forecast by Treatment
8.4. Europe Allergy Immunotherapy Market Size and Forecast by Distribution Channel
8.5. UK Allergy Immunotherapy Market
8.6. Germany Allergy Immunotherapy Market
8.7. France Allergy Immunotherapy Market
8.8. Rest of Europe Allergy Immunotherapy Market
9. Asia Pacific Allergy Immunotherapy Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Asia Pacific Allergy Immunotherapy Market Size and Forecast by Type
9.3. Asia Pacific Allergy Immunotherapy Market Size and Forecast by Treatment
9.4. Asia Pacific Allergy Immunotherapy Market Size and Forecast by Distribution Channel
9.5. China Allergy Immunotherapy Market
9.6. India Allergy Immunotherapy Market
9.7. Japan Allergy Immunotherapy Market
9.8. Rest of Asia Pacific Allergy Immunotherapy Market
10. Latin America Allergy Immunotherapy Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Latin America Allergy Immunotherapy Market Size and Forecast by Type
10.3. Latin America Allergy Immunotherapy Market Size and Forecast by Treatment
10.4. Latin America Allergy Immunotherapy Market Size and Forecast by Distribution Channel
10.4.1. Brazil Allergy Immunotherapy Market
10.4.2. Mexico Allergy Immunotherapy Market
10.4.3. Rest of Latin America Allergy Immunotherapy Market
11. MEA Allergy Immunotherapy Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. MEA Allergy Immunotherapy Market Size and Forecast by Type
11.3. MEA Allergy Immunotherapy Market Size and Forecast by Treatment
11.4. MEA Allergy Immunotherapy Market Size and Forecast by Distribution Channel
11.5. GCC Allergy Immunotherapy Market
11.6. South Africa Allergy Immunotherapy Market
11.7. Rest of MEA Allergy Immunotherapy Market
12. Companies in the Allergy Immunotherapy Market
12.1. Schering-Plough Corporation
12.1.1. Company Snapshot
12.1.2. Company Overview
12.1.3. Financial Performance (2015-2019)
12.1.3.1. Net Revenue
12.1.3.2. Gross Profit
12.1.3.3. Geographical Revenue, 2019
12.1.4. Product Offerings
12.1.5. Recent Initiatives (2017-2019)
12.2. Allergopharma
12.2.1. Company Snapshot
12.2.2. Company Overview
12.2.3. Financial Performance (2015-2019)
12.2.3.1. Net Revenue
12.2.3.2. Gross Profit
12.2.3.3. Geographical Revenue, 2019
12.2.4. Product Offerings
12.2.5. Recent Initiatives (2017-2019)
12.3. Allergon AB
12.3.1. Company Snapshot
12.3.2. Company Overview
12.3.3. Financial Performance (2015-2019)
12.3.3.1. Net Revenue
12.3.3.2. Gross Profit
12.3.3.3. Geographical Revenue, 2019
12.3.4. Product Offerings
12.3.5. Recent Initiatives (2017-2019)
12.4. Alerpharma S.A.
12.4.1. Company Snapshot
12.4.2. Company Overview
12.4.3. Financial Performance (2015-2019)
12.4.3.1. Net Revenue
12.4.3.2. Gross Profit
12.4.3.3. Geographical Revenue, 2019
12.4.4. Product Offerings
12.4.5. Recent Initiatives (2017-2019)
12.5. Allergan, Inc.
12.5.1. Company Snapshot
12.5.2. Company Overview
12.5.3. Financial Performance (2015-2019)
12.5.3.1. Net Revenue
12.5.3.2. Gross Profit
12.5.3.3. Geographical Revenue, 2019
12.5.4. Product Offerings
12.5.5. Recent Initiatives (2017-2019)
12.6. Genentech Inc.
12.6.1. Company Snapshot
12.6.2. Company Overview
12.6.3. Financial Performance (2015-2019)
12.6.3.1. Net Revenue
12.6.3.2. Gross Profit
12.6.3.3. Geographical Revenue, 2019
12.6.4. Product Offerings
12.6.5. Recent Initiatives (2017-2019)
12.7. Schering-Plough Corporation
12.7.1. Company Snapshot
12.7.2. Company Overview
12.7.3. Financial Performance (2015-2019)
12.7.3.1. Net Revenue
12.7.3.2. Gross Profit
12.7.3.3. Geographical Revenue, 2019
12.7.4. Product Offerings
12.7.5. Recent Initiatives (2017-2019)
12.8. McNeil Consumer Healthcare
12.8.1. Company Snapshot
12.8.2. Company Overview
12.8.3. Financial Performance (2015-2019)
12.8.3.1. Net Revenue
12.8.3.2. Gross Profit
12.8.3.3. Geographical Revenue, 2019
12.8.4. Product Offerings
12.8.5. Recent Initiatives (2017-2019)
12.9. Collegium Pharmaceutical, Inc.
12.9.1. Company Snapshot
12.9.2. Company Overview
12.9.3. Financial Performance (2015-2019)
12.9.3.1. Net Revenue
12.9.3.2. Gross Profit
12.9.3.3. Geographical Revenue, 2019
12.9.4. Product Offerings
12.9.5. Recent Initiatives (2017-2019)
12.10. Meda Pharmaceuticals, Inc.
12.10.1. Company Snapshot
12.10.2. Company Overview
12.10.3. Financial Performance (2015-2019)
12.10.3.1. Net Revenue
12.10.3.2. Gross Profit
12.10.3.3. Geographical Revenue, 2019
12.10.4. Product Offerings
12.10.5. Recent Initiatives (2017-2019)
12.11. Other Notable Players
13. Conclusion
14. Glossary
Associated Visiongain Reports
Visiongain Report Sales Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1 Allergy Immunotherapy Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2 Allergy Immunotherapy Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3 Allergy Immunotherapy Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4 Allergy Immunotherapy Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5 Allergy Immunotherapy Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6 Allergy Immunotherapy Market Drivers & Restraints 2020
Table 7 Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 8 Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 9 Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 10 Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 11 Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 12 Eye Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13 Eye Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14 Eye Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15 Eye Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16 Eye Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17 Skin Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 18 Skin Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 19 Skin Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 20 Skin Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 21 Food Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 22 Food Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 23 Food Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 24 Food Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 25 Food Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 26 Asthma Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 27 Asthma Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 28 Asthma Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 29 Asthma Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 30 Asthma Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 31 Rhinitis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 32 Rhinitis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 33 Rhinitis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 34 Rhinitis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 35 Rhinitis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 36 Other Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 37 Other Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 38 Other Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 39 Other Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 40 Other Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 41 Allergy Immunotherapy Submarket Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 42 Allergy Immunotherapy Submarket Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 43 Allergy Immunotherapy Submarket Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 44 Allergy Immunotherapy Submarket Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 45 Allergy Immunotherapy Submarket Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 46 Anti-Allergy Drugs Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) before COVID)
Table 47 Anti-Allergy Drugs Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 48 Anti-Allergy Drugs Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 49 Anti-Allergy Drugs Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 50 Anti-Allergy Drugs Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 51 Immunotherapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 52 Immunotherapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 53 Immunotherapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 54 Immunotherapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 55 Immunotherapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 56 Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 57 Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 58 Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 59 Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 60 Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 61 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 62 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 63 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 64 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 65 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 66 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 67 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 68 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 69 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 70 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 71 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 72 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 73 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 74 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 75 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 76 Regional Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 77 Regional Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 78 Regional Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 79 Regional Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 80 Regional Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 81 North America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 82 North America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 83 North America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 84 North America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 85 North America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 86 North America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 87 North America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 88 North America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 89 North America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 90 North America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 91 North America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 92 North America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 93 North America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 94 North America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 95 North America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 96 North America Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 97 North America Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 98 North America Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 99 North America Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 100 North America Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 101 US Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 102 US Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 103 US Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 104 US Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 105 US Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 106 Canada Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 107 Canada Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 108 Canada Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 109 Canada Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 110 Canada Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 111 Europe Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 112 Europe Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 113 Europe Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 114 Europe Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 115 Europe Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 116 Europe Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 117 Europe Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 118 Europe Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 119 Europe Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 120 Europe Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 121 Europe Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 122 Europe Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 123 Europe Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 124 Europe Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 125 Europe Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 126 Europe Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 127 Europe Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 128 Europe Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 129 Europe Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 130 Europe Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 131 UK Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 132 UK Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 133 UK Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 134 UK Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 135 UK Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 136 Germany Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 137 Germany Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 138 Germany Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 139 Germany Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 140 Germany Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 141 France Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 142 France Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 143 France Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 144 France Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 145 France Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 146 Rest of Europe Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 147 Rest of Europe Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 148 Rest of Europe Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 149 Rest of Europe Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 150 Rest of Europe Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 151 Asia Pacific Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 152 Asia Pacific Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 153 Asia Pacific Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 154 Asia Pacific Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 155 Asia Pacific Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 156 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 157 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 158 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 159 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 160 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 161 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 162 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 163 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 164 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 165 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 166 Asia Pacific Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 167 Asia Pacific Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 168 Asia Pacific Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 169 Asia Pacific Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 170 Asia Pacific Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 171 China Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 172 China Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 173 China Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 174 China Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 175 China Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 176 India Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 177 India Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 178 India Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 179 India Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 180 India Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 181 Japan Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 182 Japan Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 183 Japan Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 184 Japan Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 185 Japan Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 186 RoAPAC Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 187 RoAPAC Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 188 RoAPAC Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 189 RoAPAC Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 190 RoAPAC Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 191 Middle East Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 192 Middle East Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 193 Middle East Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 194 Middle East Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 195 Middle East Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 196 Middle East Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 197 Middle East Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 198 Middle East Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 199 Middle East Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 200 Middle East Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 201 Middle East Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 202 Middle East Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 203 Middle East Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 204 Middle East Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 205 Middle East Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 206 Latin America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 207 Latin America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 208 Latin America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 209 Latin America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 210 Latin America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 211 Latin America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 212 Latin America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 213 Latin America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 214 Latin America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 215 Latin America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 216 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 217 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 218 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 219 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 220 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 221 Africa Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 222 Africa Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 223 Africa Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 224 Africa Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 225 Africa Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 226 Africa Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 227 Africa Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 228 Africa Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 229 Africa Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 230 Africa Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 231 Africa Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 232 Africa Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233 Africa Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234 Africa Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235 Africa Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236 Leading 10 Allergy Immunotherapy Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 237 Allergy therapeutics Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 238 Allergy therapeutics Allergy Immunotherapy Selected Recent Contracts 2019 (Date, Contract Type, Details)
Table 239 Allergy therapeutics Allergy Immunotherapy Product Offering (Segment, Product Offerings)
Table 240 Allergopharma Profile 2019 (CEO, HQ, Founded, Website)
Table 241 Allergopharma Allergy Immunotherapy Selected Recent Contracts 2019 (Date, Contract Type, Details)
Table 242 Allergopharma Allergy Immunotherapy Product Offering (Segment, Product Offerings)
Table 243 Allergon AB Profile 2019 (CEO, HQ, Founded, Website)
Table 244 Allergon AB Allergy Immunotherapy Selected Recent Contracts 2017-2019 (Date, Contract Type, Details)
Table 245 Allergon AB Allergy Immunotherapy Product Offering (Segment, Product Offerings)
Table 246 Alerpharma S.A. Profile 2019 (CEO, HQ, Founded, Website)
Table 247 Alerpharma S.A. Allergy Immunotherapy Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 248 Alerpharma S.A. Allergy Immunotherapy Product Offering (Segment, Product Offerings)
Table 249 Allergan, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 250 Allergan, Inc. Allergy Immunotherapy Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 251 Allergan, Inc. Allergy Immunotherapy Product Offering (Segment, Product Offerings)
Table 252 Genentech Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 253 Genentech Inc. Allergy Immunotherapy Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 254 Genentech Inc. Allergy Immunotherapy Product Offering (Segment, Product Offerings)
Table 255 Schering-Plough Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 256 Schering-Plough Corporation Allergy Immunotherapy Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 257 Schering-Plough Corporation Allergy Immunotherapy Product Offering (Segment, Product Offerings)
Table 258 McNeil Consumer Healthcare Profile 2019 (CEO, HQ, Founded, Website)
Table 259 McNeil Consumer Healthcare Allergy Immunotherapy Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 260 McNeil Consumer Healthcare Allergy Immunotherapy Product Offering (Segment, Product Offerings)
Table 261 Collegium Pharmaceutical, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 262 Collegium Pharmaceutical, Inc. Allergy Immunotherapy Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 263 Collegium Pharmaceutical, Inc. Allergy Immunotherapy Product Offering (Segment, Product Offerings)
Table 264 Meda Pharmaceuticals, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 265 Meda Pharmaceuticals, Inc. Allergy Immunotherapy Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 266 Meda Pharmaceuticals, Inc. Allergy Immunotherapy Product Offering (Segment, Product Offerings)
Table 267 Other Companies Involved in the Allergy Immunotherapy Market 2020 (Company, Location)
LIST OF FIGURES
Figure 1 Allergy Immunotherapy Market by Treatment Overview
Figure 2 Allergy Immunotherapy Market by Treatment Overview
Figure 3 Allergy Immunotherapy Market by Treatment Overview
Figure 4 Allergy Immunotherapy Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 5 Allergy Immunotherapy Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 6 Allergy Immunotherapy Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 7 Allergy Immunotherapy Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 8 Allergy Immunotherapy Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 9 Allergy Immunotherapy Market Drivers & Restraints 2020
Figure 10 Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 11 Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 12 Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 13 Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 14 Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 15 Eye Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 16 Eye Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 17 Eye Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 18 Eye Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 19 Eye Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 20 Skin Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 21 Skin Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 22 Skin Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 23 Skin Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 24 Food Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 25 Food Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 26 Food Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 27 Food Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 28 Food Allergy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 29 Asthma Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 30 Asthma Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 31 Asthma Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 32 Asthma Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 33 Asthma Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 34 Rhinitis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 35 Rhinitis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 36 Rhinitis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 37 Rhinitis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 38 Rhinitis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 39 Other Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 40 Other Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 41 Other Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 42 Other Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 43 Other Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 44 Allergy Immunotherapy Submarket Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 45 Allergy Immunotherapy Submarket Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 46 Allergy Immunotherapy Submarket Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 47 Allergy Immunotherapy Submarket Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 48 Allergy Immunotherapy Submarket Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 49 Anti-Allergy Drugs Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) before COVID)
Figure 50 Anti-Allergy Drugs Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 51 Anti-Allergy Drugs Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 52 Anti-Allergy Drugs Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 53 Anti-Allergy Drugs Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 54 Immunotherapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 55 Immunotherapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 56 Immunotherapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 57 Immunotherapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 58 Immunotherapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 59 Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 60 Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 61 Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 62 Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 63 Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 64 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 65 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 66 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 67 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 68 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 69 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 70 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 71 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 72 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 73 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 74 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 75 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 76 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 77 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 78 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 79 Regional Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 80 Regional Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 81 Regional Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 82 Regional Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 83 Regional Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 84 North America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 85 North America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 86 North America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 87 North America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 88 North America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 89 North America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 90 North America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 91 North America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 92 North America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 93 North America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 94 North America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 95 North America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 96 North America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 97 North America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 98 North America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 99 North America Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 100 North America Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 101 North America Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 102 North America Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 103 North America Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 104 US Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 105 US Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 106 US Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 107 US Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 108 US Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 109 Canada Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 110 Canada Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 111 Canada Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 112 Canada Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 113 Canada Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 114 Europe Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 115 Europe Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 116 Europe Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 117 Europe Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 118 Europe Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 119 Europe Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 120 Europe Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 121 Europe Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 122 Europe Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 123 Europe Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 124 Europe Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 125 Europe Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 126 Europe Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 127 Europe Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 128 Europe Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 129 Europe Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 130 Europe Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 131 Europe Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 132 Europe Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 133 Europe Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 134 UK Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 135 UK Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 136 UK Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 137 UK Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 138 UK Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 139 Germany Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 140 Germany Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 141 Germany Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 142 Germany Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 143 Germany Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 144 France Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 145 France Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 146 France Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 147 France Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 148 France Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 149 Rest of Europe Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 150 Rest of Europe Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 151 Rest of Europe Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 152 Rest of Europe Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 153 Rest of Europe Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 154 Asia Pacific Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 155 Asia Pacific Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 156 Asia Pacific Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 157 Asia Pacific Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 158 Asia Pacific Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 159 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 160 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 161 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 162 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 163 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 164 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 165 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 166 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 167 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 168 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 169 Asia Pacific Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 170 Asia Pacific Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 171 Asia Pacific Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 172 Asia Pacific Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 173 Asia Pacific Allergy Immunotherapy Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 174 China Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 175 China Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 176 China Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 177 China Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 178 China Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 179 India Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 180 India Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 181 India Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 182 India Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 183 India Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 184 Japan Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 185 Japan Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 186 Japan Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 187 Japan Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 188 Japan Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 189 RoAPAC Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 190 RoAPAC Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 191 RoAPAC Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 192 RoAPAC Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 193 RoAPAC Allergy Immunotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 194 Middle East Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 195 Middle East Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 196 Middle East Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 197 Middle East Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 198 Middle East Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 199 Middle East Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 200 Middle East Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 201 Middle East Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 202 Middle East Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 203 Middle East Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 204 Middle East Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 205 Middle East Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 206 Middle East Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 207 Middle East Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 208 Middle East Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 209 Latin America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 210 Latin America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 211 Latin America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 212 Latin America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 213 Latin America Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 214 Latin America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 215 Latin America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 216 Latin America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 217 Latin America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 218 Latin America Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 219 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 220 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 221 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 222 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 223 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 224 Africa Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 225 Africa Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 226 Africa Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 227 Africa Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 228 Africa Allergy Immunotherapy Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 229 Africa Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 230 Africa Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 231 Africa Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 232 Africa Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 233 Africa Allergy Immunotherapy Market Forecast by Treatment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 234 Africa Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 235 Africa Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 236 Africa Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 237 Africa Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 238 Africa Allergy Immunotherapy Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Companies Profiled in the Report
1. Allergy therapeutics
2. Allergopharma
3. Allergon AB
4. Alerpharma S.A.
5. Allergan, Inc.
6. Genentech Inc.
7. Schering-Plough Corporation
8. McNeil Consumer Healthcare
9. Collegium Pharmaceutical, Inc.
10. Meda Pharmaceuticals, Inc.
11. Sepracor, Inc.
12. Vicks
List of Companies Mentioned in the Report:
1. Shionogi & Co.
2. Shanghai Fosun Pharmaceutical
3. Stada Arzneimittel
4. Lundbeck
5. Zhejiang International
6. Lupin
7. Taisho Pharmaceutical
8. Tasly Pharmaceutical
9. Ipsen
10. Sino Biopharmaceutical
11. Ono Pharmaceutical
12. Aurobindo
13. Cipla
14. Johnson & Johnson
15. Roche
16. Novartis
17. Sanofi
18. Bayer
19. Merck & Co. (MSD)
20. Eli Lilly
21. Astrazeneca
22. Teva
23. CR Pharmaceutical
24. Bristol-Myers Squibb
25. Merck (KGaA)
26. Novo Nordisk
27. Takeda
28. Allergan
29. Astellas Pharma
30. Mylan
31. Otsuka
32. Daiichi Sankyo
33. Valeant Pharmaceuticals
34. UCB
35. Zoetis
36. Eisai
37. Chugai Pharmaceutical
38. Perrigo
39. Sun Pharmaceutical
40. Mitsubishi Tanabe Pharma
41. Sichuan Languang Development
42. Sumitomo Dainippon Pharma
43. Yunnan Baiyao
44. Aspen Pharmacare
45. Endo
46. Kangmei Pharmaceutical
47. Galenica
48. Guangzhou Baiyunshan Pharmaceutical
49. Kyowa Hakko Kirin
50. Mallinckrod
List of Organizations Mentioned in the Report:
1. European Commission
2. European Medicines Agency
3. Food and Drug Administration
4. Medicines and Healthcare Regulatory Agency
5. Ministry of Industry and Information technology
6. National Institute of Health
7. World Health Organisation (WHO)
8. Centers for Disease Control and Prevention
9. National Academy of Medicine
10. Agency for Healthcare Research and Quality
11. National Accreditation Board for Hospitals & Healthcare Providers
12. National Institute for Health Research
13. Chinese Food and Drug Administration
14. Care Quality Commission
15. British Medical Association
16. United States Department of Health and Human Services
17. Healthcare Information and Management Systems Society
18. Patient safety organization
19. NHS Digital
20. Australian Commission On Safety And Quality In Health Care
1. Allergy therapeutics
2. Allergopharma
3. Allergon AB
4. Alerpharma S.A.
5. Allergan, Inc.
6. Genentech Inc.
7. Schering-Plough Corporation
8. McNeil Consumer Healthcare
9. Collegium Pharmaceutical, Inc.
10. Meda Pharmaceuticals, Inc.
11. Sepracor, Inc.
12. Vicks
List of Companies Mentioned in the Report:
1. Shionogi & Co.
2. Shanghai Fosun Pharmaceutical
3. Stada Arzneimittel
4. Lundbeck
5. Zhejiang International
6. Lupin
7. Taisho Pharmaceutical
8. Tasly Pharmaceutical
9. Ipsen
10. Sino Biopharmaceutical
11. Ono Pharmaceutical
12. Aurobindo
13. Cipla
14. Johnson & Johnson
15. Roche
16. Novartis
17. Sanofi
18. Bayer
19. Merck & Co. (MSD)
20. Eli Lilly
21. Astrazeneca
22. Teva
23. CR Pharmaceutical
24. Bristol-Myers Squibb
25. Merck (KGaA)
26. Novo Nordisk
27. Takeda
28. Allergan
29. Astellas Pharma
30. Mylan
31. Otsuka
32. Daiichi Sankyo
33. Valeant Pharmaceuticals
34. UCB
35. Zoetis
36. Eisai
37. Chugai Pharmaceutical
38. Perrigo
39. Sun Pharmaceutical
40. Mitsubishi Tanabe Pharma
41. Sichuan Languang Development
42. Sumitomo Dainippon Pharma
43. Yunnan Baiyao
44. Aspen Pharmacare
45. Endo
46. Kangmei Pharmaceutical
47. Galenica
48. Guangzhou Baiyunshan Pharmaceutical
49. Kyowa Hakko Kirin
50. Mallinckrod
List of Organizations Mentioned in the Report:
1. European Commission
2. European Medicines Agency
3. Food and Drug Administration
4. Medicines and Healthcare Regulatory Agency
5. Ministry of Industry and Information technology
6. National Institute of Health
7. World Health Organisation (WHO)
8. Centers for Disease Control and Prevention
9. National Academy of Medicine
10. Agency for Healthcare Research and Quality
11. National Accreditation Board for Hospitals & Healthcare Providers
12. National Institute for Health Research
13. Chinese Food and Drug Administration
14. Care Quality Commission
15. British Medical Association
16. United States Department of Health and Human Services
17. Healthcare Information and Management Systems Society
18. Patient safety organization
19. NHS Digital
20. Australian Commission On Safety And Quality In Health Care
Download sample pages
Complete the form below to download your free sample pages for Allergy Treatment Market Report to 2031Download sample pages
Complete the form below to download your free sample pages for Allergy Treatment Market Report to 2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024
Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034
The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.
12 April 2024
Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034
The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.
11 April 2024
